Wave Life Sciences (WVE) Invested Capital (2016 - 2025)
Wave Life Sciences (WVE) has disclosed Invested Capital for 11 consecutive years, with $518.4 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Invested Capital rose 147.41% year-over-year to $518.4 million, compared with a TTM value of $518.4 million through Dec 2025, up 147.41%, and an annual FY2025 reading of $518.4 million, up 147.41% over the prior year.
- Invested Capital was $518.4 million for Q4 2025 at Wave Life Sciences, up from $124.5 million in the prior quarter.
- Across five years, Invested Capital topped out at $518.4 million in Q4 2025 and bottomed at -$51.7 million in Q2 2023.
- Average Invested Capital over 5 years is $67.9 million, with a median of $30.4 million recorded in 2021.
- The sharpest move saw Invested Capital crashed 65398.11% in 2023, then skyrocketed 4105.35% in 2025.
- Year by year, Invested Capital stood at $32.5 million in 2021, then crashed by 238.75% to -$45.1 million in 2022, then soared by 187.89% to $39.6 million in 2023, then skyrocketed by 428.68% to $209.5 million in 2024, then soared by 147.41% to $518.4 million in 2025.
- Business Quant data shows Invested Capital for WVE at $518.4 million in Q4 2025, $124.5 million in Q3 2025, and $139.3 million in Q2 2025.